Smith & Nephew (LON:SN) Earns “Buy” Rating from Jefferies Financial Group

Jefferies Financial Group reiterated their buy rating on shares of Smith & Nephew (LON:SN) in a research note released on Friday, MarketBeat.com reports. They currently have a GBX 1,250 ($15.70) target price on the stock.

SN has been the topic of several other research reports. Royal Bank of Canada reaffirmed an outperform rating and set a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a research report on Friday, April 5th. Barclays reaffirmed an equal weight rating and set a GBX 1,150 ($14.45) price objective on shares of Smith & Nephew in a research report on Friday, February 9th. Berenberg Bank restated a buy rating and issued a GBX 1,450 ($18.21) price objective on shares of Smith & Nephew in a research note on Thursday. Finally, JPMorgan Chase & Co. increased their target price on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an overweight rating in a research note on Thursday. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of GBX 1,346.20 ($16.91).

Smith & Nephew Trading Up 1.1 %

SN stock opened at GBX 996.80 ($12.52) on Friday. The company has a current ratio of 1.77, a quick ratio of 0.84 and a debt-to-equity ratio of 59.11. Smith & Nephew has a 12-month low of GBX 887 ($11.14) and a 12-month high of GBX 1,316.75 ($16.54). The stock has a market cap of £8.72 billion, a price-to-earnings ratio of 4,153.33, a PEG ratio of 0.46 and a beta of 0.51. The business’s 50-day moving average is GBX 1,018.36 and its 200 day moving average is GBX 1,035.73.

Smith & Nephew Increases Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.23 per share. The ex-dividend date is Thursday, March 28th. This represents a dividend yield of 1.62%. This is an increase from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio is currently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.